These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2282487)

  • 1. Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
    Batt CM; Jensen LL; Hanesworth JM; Harding JW; Wright JW
    Brain Res; 1990 Oct; 529(1-2):126-30. PubMed ID: 2282487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
    Batt CM; Klein EW; Harding JW; Wright JW
    Brain Res Bull; 1988 Nov; 21(5):731-5. PubMed ID: 3219604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
    Sullivan MJ; Harding JW; Wright JW
    Brain Res; 1988 Jul; 456(2):249-53. PubMed ID: 3208081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ; Cunoosamy MP; Clark KL
    Br J Pharmacol; 1992 May; 106(1):166-72. PubMed ID: 1354540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.
    Wright JW; Quirk WS; Hanesworth JM; Harding JW
    Brain Res; 1988 Feb; 441(1-2):215-20. PubMed ID: 3359232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat.
    Dewey AL; Wright JW; Hanesworth JM; Harding JW
    Brain Res; 1988 May; 448(2):369-72. PubMed ID: 3378160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS; Harding JW; Wright JW
    Brain Res Bull; 1987 Jul; 19(1):145-7. PubMed ID: 3651838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
    Wright JW; Sullivan MJ; Quirk WS; Batt CM; Harding JW
    J Hypertens Suppl; 1986 Dec; 4(6):S408-11. PubMed ID: 3475426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH; Sullivan MJ; Wright JW; Harding JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains.
    Jensen LL; Harding JW; Wright JW
    Brain Res; 1989 Jun; 490(1):48-55. PubMed ID: 2758329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
    Zini S; Fournie-Zaluski MC; Chauvel E; Roques BP; Corvol P; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11968-73. PubMed ID: 8876246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion].
    Llorens-Cortes C
    C R Seances Soc Biol Fil; 1998; 192(4):607-18. PubMed ID: 9842467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain angiotensin: critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function.
    Harding JW; Jensen LL; Quirk WS; Dewey AL; Wright JW
    Peptides; 1989; 10(2):261-4. PubMed ID: 2755868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amastatin potentiation of drinking induced by blood-borne angiotensin: evidence for mediation by endogenous brain angiotensin.
    Sullivan MJ; Beltz TG; Johnson AK
    Brain Res; 1990 Mar; 510(2):237-41. PubMed ID: 2331601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypothalamic-angiotensin system: location and functional considerations.
    Felix D; Harding JW; Imboden H
    Clin Exp Hypertens A; 1988; 10 Suppl 1():45-62. PubMed ID: 3243007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in baroreceptor reflex response by angiotension III and its modification by Ile7-angiotensin III and bestatin in the rat.
    Lin KS; Chan JY; Chan SH
    Neurosci Lett; 1988 Jul; 90(1-2):172-6. PubMed ID: 3412638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidase inhibitor-induced antidiuresis mediated through angiotensin and opioid receptors in the rat hypothalamus.
    Tsushima H; Mori M; Matsuda T
    Jpn J Pharmacol; 1996 May; 71(1):61-71. PubMed ID: 8791172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analyses of brain angiotensin control of pressor action in rats.
    Wright JW; Jensen LL; Roberts KA; Sardinia MF; Harding JW
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1551-7. PubMed ID: 2604011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of dermorphin-induced antinociception by peptidase inhibitors.
    Sakurada S; Watanabe H; Sakurada T; Andoh R; Kisara K; Sasaki Y; Suzuki K
    J Pharm Pharmacol; 1986 Mar; 38(3):230-2. PubMed ID: 2871164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.